Largest biotech by total assets
Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.
Kodiak Sciences has the lowest figure of the 24 biotech ranked by total assets, at CHF 296.5M, followed by Scholar Rock Holding (CHF 340.9M) and ImmunityBio (CHF 423.3M). Figures as of 18 Nov 2026, 16:15 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 24
- Lowest
- Kodiak SciencesCHF 296.5M
- Median
- CHF 2.2B
- Combined market value
- CHF 707.4B
- Countries
- 5
Market values as of .
All countries▾
All sectors▾
Biotech▾
| # | Company | Total assets ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Kodiak SciencesKOD · Health Care | CHF 296.5M | CHF 5.3B | CHF 81.14 | 0.60% down | 396% up | ||
| 2 | Scholar Rock HoldingSRRK · Health Care | CHF 340.9M | CHF 4.9B | CHF 39.91 | 4.99% up | 14% up | ||
| 3 | ImmunityBioIBRX · Health Care | CHF 423.3M | CHF 5.9B | CHF 5.57 | 5.43% up | 193% up | ||
| 4 | Adaptive BiotechnologiesADPT · Health Care | CHF 432.4M | CHF 3.8B | CHF 23.71 | 1.30% down | 88% up | ||
| 5 | Twist BioscienceTWST · Health Care | CHF 541.3M | CHF 6.6B | CHF 96.94 | 2.63% up | 340% up | ||
| 6 | CG OncologyCGON · Health Care | CHF 667.6M | CHF 6B | CHF 67.12 | 0.82% up | 85% up | ||
| 7 | ImmunovantIMVT · Health Care | CHF 807.1M | CHF 5.9B | CHF 28.37 | 1.28% up | 43% up | ||
| 8 | Krystal BiotechKRYS · Health Care | CHF 1.1B | CHF 7.7B | CHF 260.22 | 3.35% up | 46% up | ||
| 9 | Kymera TherapeuticsKYMR · Health Care | CHF 1.5B | CHF 8.7B | CHF 101.79 | 0.67% down | 87% up | ||
| 10 | CRISPR TherapeuticsCRSP · Health Care | CHF 1.9B | CHF 3.4B | CHF 34.85 | 2.94% up | 21% down | ||
| 11 | Revolution MedicinesRVMD · Health Care | CHF 2B | CHF 29.2B | CHF 134.93 | 1.65% down | 131% up | ||
| 12 | Halozyme TherapeuticsHALO · Health Care | CHF 2.1B | CHF 9.3B | CHF 81.75 | 1.01% up | 37% up | ||
| 13 | Bio-TechneTECH · Health Care | CHF 2.2B | CHF 9.6B | CHF 61.33 | 0.13% up | 26% up | ||
| 14 | ExelixisEXEL · Health Care | CHF 2.4B | CHF 14.2B | CHF 58.12 | 0.61% up | 63% up | ||
| 15 | RepligenRGEN · Health Care | CHF 2.5B | CHF 9.2B | CHF 143.85 | 5.17% up | 5% up | ||
| 16 | VaxcytePCVX · Health Care | CHF 2.5B | CHF 7.9B | CHF 49.68 | 0.82% down | 22% up | ||
| 17 | Neurocrine BiosciencesNBIX · Health Care | CHF 3.9B | CHF 13.9B | CHF 136.96 | 2.12% down | 20% up | ||
| 18 | QiagenQGEN · Health Care | CHF 5.3B | CHF 8.6B | CHF 41.80 | 0.37% down | 12% up | ||
| 19 | argenxARGX · Health Care | CHF 7.3B | CHF 50.2B | CHF 797.75 | 0.16% down | 4% up | ||
| 20 | ModernaMRNA · Health Care | CHF 10.4B | CHF 68.5B | CHF 169.24 | 2.96% down | 755% up | ||
| 21 | BioNTechBNTX · Health Care | CHF 20.6B | CHF 17.6B | CHF 70.84 | 1.01% down | 16% down | ||
| 22 | BiogenBIIB · Health Care | CHF 24.8B | CHF 31.1B | CHF 210.37 | 0.53% down | 49% up | ||
| 23 | Gilead SciencesGILD · Health Care | CHF 49.8B | CHF 176.3B | CHF 142.11 | 1.02% down | 33% up | ||
| 24 | AmgenAMGN · Health Care | CHF 76.4B | CHF 203.8B | CHF 376.74 | 2.44% down | 34% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 0.8433 CHF).
Questions and answers
Which biotech have the lowest total assets?
Kodiak Sciences (CHF 296.5M), Scholar Rock Holding (CHF 340.9M) and ImmunityBio (CHF 423.3M) have the lowest total assets of the 24 biotech ranked here as of 18 Nov 2026, 16:15 UTC.
How many biotech are in this ranking?
24 are ranked by total assets.
What are these biotech worth together?
The 24 biotech ranked by total assets have a combined market value of CHF 707.4B as of 18 Nov 2026, 16:15 UTC.
What does ranking by total assets measure?
Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest biotech by total assets”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=total-assets
Underlying data: Yahoo Finance; SEC EDGAR.